HEXTEND (6% Hetastarch in Lactated Electrolyte Injection) is an artificial colloidal solution, pharmacologically classified as a plasma volume expander, and is intended to support oncotic pressure as well as provide electrolytes.
Manufactured and Distributed by:Hospira, Inc., Lake Forest, IL 60045, USA
Under license from BioTime, Inc., Berkeley, CA 94710, USA
BioTime, Inc.
1301 Harbor Bay Pkwy
Alameda, CA 94502
tel: 510.521.3390
fax: 510.521.3389